日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinoma

AdvanTIG-206:一项II期随机研究,比较奥西哌利单抗联合替雷利珠单抗和BAT1706(贝伐珠单抗生物类似药)与替雷利珠单抗联合BAT1706一线治疗肝细胞癌的疗效。

Ren, Zhenggang; Huang, Yao; Guo, Yabing; Hou, Ming-Mo; Wang, Wei; Kuang, Ming; Hao, Chunyi; Wang, Wentao; Zhang, Yanqiao; Song, Tianqiang; Dai, Chaoliu; Kuo, Hsing-Tao; Bao, Zinan; Zuo, Yunxia; Wang, Lei; Zhu, Fuxiang; Fan, Jia

Longer Lifetime of BC from Fossil Fuel Combustion than from Biomass Burning: Δ(14)C Evidence

化石燃料燃烧产生的黑碳寿命比生物质燃烧产生的黑碳寿命更长:Δ(14)C 证据

Li, Chaoliu; Hu, Zhaofu; Kang, Shichang; Kirillova, Elena N; Yan, Fangping; Chen, Pengfei; Shen, Guofeng; Jake, Thompson T; Gustafsson, Örjan

Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition)

中国肝细胞癌全程管理专家共识(2023版)

Yang, Yu; Sun, Juxian; Cai, Jianqiang; Chen, Minshan; Dai, Chaoliu; Wen, Tianfu; Xia, Jinglin; Ying, Mingang; Zhang, Zhiwei; Zhang, Xuewen; Fang, Chihua; Shen, Feng; An, Ping; Cai, Qingxian; Cao, Jingyu; Zeng, Zhen; Chen, Gang; Chen, Juan; Chen, Ping; Chen, Yongshun; Shan, Yunfeng; Dang, Shuangsuo; Guo, Wei-Xing; He, Jiefeng; Hu, Heping; Huang, Bin; Jia, Weidong; Jiang, Kexiang; Jin, Yan; Jin, Yongdong; Jin, Yun; Li, Gong; Liang, Yun; Liu, Enyu; Liu, Hao; Peng, Wei; Peng, Zhenwei; Peng, Zhiyi; Qian, Yeben; Ren, Wanhua; Shi, Jie; Song, Yusheng; Tao, Min; Tie, Jun; Wan, Xueying; Wang, Bin; Wang, Jin; Wang, Kai; Wang, Kang; Wang, Xin; Wei, Wenjing; Wu, Fei-Xiang; Xiang, Bangde; Xie, Lin; Xu, Jianming; Yan, Mao-Lin; Ye, Yufu; Yue, Jinbo; Zhang, Xiaoxun; Zhang, Yu; Zhang, Aibin; Zhao, Haitao; Zhao, Weifeng; Zheng, Xin; Zhou, Hongkun; Zhou, Huabang; Zhou, Jun; Zhou, Xinmin; Cheng, Shu-Qun; Li, Qiu

China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition)

中国肝癌诊疗指南(2024版)

Zhou, Jian; Sun, Huichuan; Wang, Zheng; Cong, Wenming; Zeng, Mengsu; Zhou, Weiping; Liu, Lianxin; Wen, Tianfu; Kuang, Ming; Zhang, Bixiang; Tao, Kaishan; Han, Guohong; Yan, Zhiping; Wang, Maoqiang; Liu, Ruibao; Guo, Jinhe; Zeng, Zhaochong; Liang, Ping; Ren, Zhenggang; Hou, Jinlin; Zhang, Yanqiao; Liu, Xiufeng; Pan, Hongming; Bi, Feng; Liang, Changhong; Chen, Min; Yan, Fuhua; Xu, Huixiong; Xie, Xiaoyan; Ju, Shenghong; Ji, Yuan; Yun, Jingping; Li, Zengshan; Bai, Xueli; Cai, Dingfang; Chen, Weixia; Chen, Yajin; Chen, Yongjun; Cheng, Wenwu; Cheng, Shuqun; Dai, Zhi; Dai, Chaoliu; Gao, Qiang; Guo, Rongping; Guo, Wengzhi; Guo, Yabing; Hua, Baojin; Huang, Xiaowu; Jiang, Hanyu; Jia, Weidong; Li, Qiu; Li, Tao; Li, Xiangcheng; Li, Xun; Li, Yaming; Li, Yexiong; Liang, Jun; Liang, Xiao; Ling, Changquan; Liu, Hui; Liu, Tianshu; Lu, Shichun; Lv, Guoyue; Mao, Yilei; Meng, Zhiqiang; Peng, Tao; Ren, Weixin; Shi, Guoming; Shi, Hongcheng; Shi, Ming; Song, Tianqiang; Tan, Guang; Wang, Jianhua; Wang, Kui; Wang, Lu; Wang, Wentao; Wang, Xiaoying; Wang, Zhiming; Xiang, Bangde; Xia, Jun; Xing, Baocai; Xu, Jianming; Xu, Jun; Yang, Jianyong; Yang, Xinrong; Yang, Yefa; Yang, Yunke; Yao, Xiaohong; Yin, Zhenyu; Yuan, Zhengang; Zeng, Yongyi; Zeng, Yong; Zhang, Boheng; Zhang, Leida; Zhang, Shuijun; Zhang, Ti; Zhang, Zhiwei; Zhao, Ming; Zhao, Yongfu; Zheng, Honggang; Zhou, Ledu; Zhu, Jiye; Zhu, Kangshun; Shi, Yinghong; Liu, Rong; Zhang, Lan; Xiao, Yongsheng; Yang, Chun; Wu, Zhifeng; Ding, Zhengbin; Zhu, Xiaodong; Tang, Zheng; Huang, Xiaoyong; Han, Hong; Wu, Hong; Chen, Minshan; Wang, Weilin; Li, Qiang; Cai, Jianqiang; Shen, Feng; Cai, Xiujun; Qin, Shukui; Teng, Gaojun; Fan, Jia

Prognostic Value of the PET/CT-Derived Maximum Standardized Uptake Value Combined with the Neutrophil-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy

PET/CT衍生的最大标准化摄取值联合中性粒细胞-淋巴细胞比值对接受肝切除术的肝细胞癌患者的预后价值

Zhou, Tianyi; Dai, Chaoliu

A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021

2020年至2021年中国三级医院肝细胞癌专家临床实践调查

Zhao, Hong; Mao, Yilei; Wang, Hongguang; Zhou, Aiping; Yang, Zhengqiang; Han, Yue; Li, Gong; Bi, Xinyu; Hao, Chunyi; Wang, Xiaodong; Zhou, Jun; Dai, Chaoliu; Wen, Feng; Zhang, Jingdong; Liu, Ruibao; Li, Tao; Zhao, Lei; Niu, Zuoxing; Wen, Tianfu; Li, Qiu; Zhang, Hongmei; Chen, Xiaoming; Chen, Minshan; Zhao, Ming; Chen, Yajin; Yu, Jun; Shen, Jie; Li, Xiangchen; Liu, Lianxin; Huang, Zhiyong; Zhang, Wei; Shen, Feng; Zhou, Weiping; Yuan, Zhengang; Zhai, Jian; Ge, Ningling; Chen, Yongjun; Sun, Huichuan; Cai, Jianqiang

Impact of three-dimensional reconstruction visualization technology on short-term and long-term outcomes after hepatectomy in patients with hepatocellular carcinoma: a propensity-score-matched and inverse probability of treatment-weighted multicenter study

三维重建可视化技术对肝细胞癌患者肝切除术后短期和长期预后的影响:一项倾向评分匹配和逆概率加权多中心研究

Zeng, Xiaojun; Tao, Haisu; Dong, Yanchen; Zhang, Yuwei; Yang, Junying; Xuan, Feichao; Zhou, Jian; Jia, Weidong; Liu, Jingfeng; Dai, Chaoliu; Hu, Haoyu; Xiang, Nan; Zeng, Ning; Zhou, Weiping; Lau, Wanyee; Yang, Jian; Fang, Chihua

Chinese expert consensus on clinical application of molecularly targeted drugs for hepatocellular carcinoma (2022 edition)

中国肝细胞癌分子靶向药物临床应用专家共识(2022版)

Sun, Juxian; Li, Qiu; Bai, Xueli; Cai, Jianqiang; Chen, Yajin; Chen, Minshan; Dai, Chaoliu; Fang, Chihua; Jia, Weidong; Li, Xiangcheng; Wen, Tianfu; Xia, Jinglin; Ying, Mingang; Zhang, Zhiwei; Zhang, Xuewen; Zeng, Zhaochong; Cheng, Shuqun

The tumor burden score may be a discriminator in microwave ablation versus liver resection for hepatocellular carcinoma within the Milan criteria: a propensity score matching and inverse probability of treatment weighting study

肿瘤负荷评分可能是区分米兰标准内肝细胞癌患者接受微波消融治疗与肝切除术的鉴别指标:一项倾向评分匹配和逆概率加权研究

Wei, Zeyuan; Xie, Kailing; Xu, Feng; Dai, Chaoliu

A Novel Prognostic Nomogram Based on TIGIT and NKG2A Can Predict Relapse-Free Survival of Hepatocellular Carcinoma After Hepatectomy

基于TIGIT和NKG2A的新型预后列线图可预测肝细胞癌肝切除术后的无复发生存期

Wang, Junqi; Cao, Yuqing; Tian, Yu; Dai, Chaoliu; Jin, Tianqiang; Xu, Feng